Category: Fetus
Poster Session I
FBetween 2014-22, 373 TTTS patients had Solomon FLS; 19.9% were Stage I, 30.6% were Stage II, 43.5% were Stage III, and 5.6% were stage IV (table). Co-existing selective fetal growth restriction was most common in stage III (p < 0.001) (Table). Solomon technique was successful in 347 (97.7%). In addition to Solomon, we also performed sequential anastomosis ablation in 51 patients with significant growth discordance (14.4%). Double survival by 48 hours after laser did not differ between TTTS stages (p=0.292). Double survival at birth occurred in 76.1% (270) patients, single survival in 16.9% (60) and 7% (25) had no survivors. Dual birth survival was statistically similar between stages, though numerically lower in Stage III (p=0.103).
Conclusion: Solomon laser achieves resolution of TTTS in a high proportion of cases allowing for disease recovery and double survival. Unequal placental sharing responsible for fetal size discordance appears to be the primary obstacle to achieve double survival.
Jannis Kyvernitakis, MD
Asklepios Kliniken
Hamburg, Germany, Germany
Mara Rosner, MD, MPH
Assistant Professor
Johns Hopkins Center for Fetal Therapy
Baltimore, Maryland, United States
Peter Wohlmuth, N/A
Asklepios Kliniken
Hamburg, Germany, Germany
Holger Maul, MD
Asklepios Kliniken
Hamburg, Germany, Germany
Jena L. Miller, MD (she/her/hers)
Assistant Professor
Johns Hopkins Center for Fetal Therapy
Baltimore, Maryland, United States
Ahmet A. Baschat, MBBCH, MD (he/him/his)
Director
Johns Hopkins Center for Fetal Therapy
Baltimore, Maryland, United States